Ammash, Omar N.

Omar N. Ammash

Associate

omar.ammash@lw.com
    Ammash, Omar N.

    Omar N. Ammash

    Associate

    omar.ammash@lw.com

    Profile

    Omar Ammash represents US and international-based startups, emerging growth companies, and venture capital investors involved in technology, life sciences, and other growth industries.
    Mr. Ammash advises clients on a full range of transactions and general corporate matters, including:

    • Venture capital financings
    • Corporate governance
    • Mergers and acquisitions
    • Day-to-day corporate advice
    • Early-stage formation and strategy

    While attending law school, he was a member of the Corporate Lab, a transactional-focused clinic, working on cutting-edge projects with multinational companies. 
     

    Experience

    Representative transactions include:

     

    Startup and Emerging Growth Company Financings: 

    • Rivian on multiple venture capital financings 
    • Celestial AI on multiple venture capital financings
    • Sleeper on its US$50m Series C fundraise
    • GT Medical Technologies on its Series C fundraise
    • Novasenta on multiple venture capital financings
    • Homie Technology on multiple venture capital financings 
    • Fluid Truck on its Series B fundraise 
    • Jetti Resources on multiple venture capital financings
    • ActiveCampaign on its US$240 million Series C financing 

     

    Venture Capital Investments:

    • Goldman Sachs on various lead investments, including in Nested Therapeutics and TORL Biotherapeutics
    • DNS Capital on various lead investments and follow-on growth financings for its portfolio companies
    • Drive Capital on various lead investments and follow-on growth financings for its portfolio companies 
    • GreatPoint Ventures on various lead investments and follow-on growth financings for its portfolio companies
    • Sea Capital in its investment in Forte’s US$725m Series B round 
    • Cadence Design Systems in multiple strategic investments
    • Softbank on various lead investments, including in Forward Health, Sprout Therapy and M1 Finance

    Mergers, Acquisitions, and Capital Markets Transactions:

    • Tegus on its acquisition of Canalyst
    • GTCR on its sale of Inteliquent to Sinch
    • Castle Creek on multiple portfolio company acquisitions, including its acquisition of Novavita 
    • Henkel on its acquisition of Momentive’s consumer sealants division
    • Blaize on its business combination with BurTech Acquisition Corp.
    • Oscar Health on its US$1.4 billion IPO
    • Aon on its US$80 billion merger of equals with Willis towers (terminated)
    • Carlyle on its acquisition of Apollo Aviation

    Qualifications

    Bar Qualification

    • Illinois

    Education

    • J.D., University of Chicago, 2017
    • BA in Political Science, University of Minnesota, 2013
      summa cum laude

    Practices

    Recognition

    News & Insights

    Read More